Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes

64Citations
Citations of this article
149Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: The electronic surveillance for adverse drug events is largely based upon the analysis of coded data from reporting systems. Yet, the vast majority of electronic health data lies embedded within the free text of clinical notes and is not gathered into centralized repositories. With the increasing access to large volumes of electronic medical data-in particular the clinical notes-it may be possible to computationally encode and to test drug safety signals in an active manner. Results: We describe the application of simple annotation tools on clinical text and the mining of the resulting annotations to compute the risk of getting a myocardial infarction for patients with rheumatoid arthritis that take Vioxx. Our analysis clearly reveals elevated risks for myocardial infarction in rheumatoid arthritis patients taking Vioxx (odds ratio 2.06) before 2005. Conclusions: Our results show that it is possible to apply annotation analysis methods for testing hypotheses about drug safety using electronic medical records.

Cite

CITATION STYLE

APA

LePendu, P., Iyer, S. V., Fairon, C., & Shah, N. H. (2012). Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes. Journal of Biomedical Semantics, 3(1). https://doi.org/10.1186/2041-1480-3-S1-S5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free